Yahoo
Tokyo - Delayed Quote JPY

Ono Pharmaceutical Co., Ltd. (4528.T)

2,256.00 +31.50 (+1.42%)
At close: October 30 at 3:30:00 PM GMT+9
View in AlphaSpace Currency in JPY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
491,153,000
515,785,000
486,871,000
502,672,000
447,187,000
Cost of Revenue
127,170,000
141,716,000
147,950,000
127,126,000
110,062,000
Gross Profit
363,983,000
374,069,000
338,921,000
375,547,000
337,124,000
Operating Expense
265,909,000
281,833,000
279,173,000
215,611,000
195,161,000
Operating Income
98,074,000
92,236,000
59,748,000
159,936,000
141,963,000
Net Non Operating Interest Income Expense
822,000
417,000
-544,000
3,798,000
1,565,000
Pretax Income
98,897,000
92,654,000
59,328,000
163,734,000
143,532,000
Tax Provision
23,936,000
22,743,000
9,163,000
35,694,000
30,619,000
Net Income Common Stockholders
74,608,000
69,767,000
50,047,000
127,977,000
112,723,000
Diluted NI Available to Com Stockholders
74,608,000
69,767,000
50,047,000
127,977,000
112,723,000
Basic EPS
158.76
148.49
106.55
266.61
230.85
Diluted EPS
158.62
148.41
106.41
266.57
230.79
Basic Average Shares
469,770.74
469,843.09
469,852
480,009
488,300.45
Diluted Average Shares
470,092.24
470,096.36
469,972
480,087.78
488,353
Total Operating Income as Reported
98,074,000
92,236,000
59,747,000
159,935,000
141,963,000
Total Expenses
393,079,000
423,549,000
427,123,000
342,737,000
305,223,000
Net Income from Continuing & Discontinued Operation
74,608,000
69,767,000
50,047,000
127,977,000
112,723,000
Normalized Income
74,608,000
69,767,000
50,047,000
127,977,000
112,723,000
Interest Income
4,353,000
3,956,000
4,774,000
4,027,000
2,478,000
Interest Expense
3,531,000
3,539,000
5,318,000
229,000
913,000
Net Interest Income
822,000
417,000
-544,000
3,798,000
1,565,000
EBIT
102,428,000
96,193,000
64,646,000
163,963,000
144,445,000
EBITDA
139,683,000
133,945,000
91,540,000
182,103,000
161,896,000
Reconciled Cost of Revenue
127,170,000
141,716,000
147,950,000
127,126,000
110,062,000
Reconciled Depreciation
37,255,000
37,752,000
26,894,000
18,140,000
17,451,000
Net Income from Continuing Operation Net Minority Interest
74,608,000
69,767,000
50,047,000
127,977,000
112,723,000
Normalized EBITDA
139,683,000
133,945,000
91,540,000
182,103,000
161,896,000
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
3/31/2023 - 1/4/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: